Dianthus Therapeutics Stock Investor Sentiment

DNTH Stock   23.83  0.03  0.13%   
Under 62% of Dianthus Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Dianthus Therapeutics stock suggests that many investors are alarmed at this time. Dianthus Therapeutics' investing sentiment shows overall attitude of investors towards Dianthus Therapeutics.
  
over six months ago at simplywall.st         
Dianthus Therapeutics First Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags
Simply Wall St News at Macroaxis
over six months ago at investorplace.com         
DNTH Stock Earnings Dianthus Therapeutics Misses EPS, Beats Revenue for Q1 2024
sbwire news
over six months ago at seekingalpha.com         
Dianthus Therapeutics GAAP EPS of -0.54 misses by 0.10, revenue of 0.87M beats by 0.5M
seekingalpha News
over six months ago at finance.yahoo.com         
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
Yahoo News
over six months ago at benzinga.com         
Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference
benzinga news
over six months ago at news.google.com         
Dianthus Therapeutics Shares Up 8.1 percent - Defense World
Google News at Macroaxis
over six months ago at globenewswire.com         
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
Dianthus Therapeutics Shares Down 8.9 percent - MarketBeat
Google News at Macroaxis
over six months ago at simplywall.st         
Insider Stock Buying Reaches US2.05m On Dianthus Therapeutics
Simply Wall St News at Macroaxis
over six months ago at news.google.com         
What 5 Analyst Ratings Have To Say About Dianthus Therapeutics - Dianthus Therapeutics - Benzinga
Google News at Macroaxis
over six months ago at news.google.com         
Dianthus Therapeutics Trading Down 4.6 percent - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Dianthus Therapeutics, Inc. Sees Significant Increase in Short Interest - MarketBeat
Google News at Macroaxis
over six months ago at news.google.com         
Dianthus Therapeutics Sees Strong Trading Volume - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Dianthus Therapeutics Sees Large Volume Increase - MarketBeat
Google News at Macroaxis
over six months ago at globenewswire.com         
Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurol...
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Dianthus Therapeutics that are available to investors today. That information is available publicly through Dianthus media outlets and privately through word of mouth or via Dianthus internal channels. However, regardless of the origin, that massive amount of Dianthus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Dianthus Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Dianthus Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Dianthus Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Dianthus Therapeutics alpha.

Dianthus Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Dianthus Stock analysis

When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins